KORU vs SPXL

Key Takeaways

• Both funds are 3x daily-reset leveraged ETFs designed for short-term trading, not buy-and-hold positioning; each seeks 300% of its underlying index's daily return, before fees and expenses.
• KORU offers concentrated single-country exposure to South Korean large- and mid-cap equities, while SPXL provides diversified exposure to roughly 500 leading U.S. large-cap companies.
• Cost structure differs meaningfully: KORU carries a net expense ratio of about 1.32%, versus approximately 0.84% for SPXL, giving SPXL a clear cost-efficiency edge.
• Sector concentration is far higher in KORU, where information technology and Samsung Electronics-related names dominate, compared with SPXL's broader, more balanced sector footprint.
• Tickeron AI Verdict: SPXL — the AI favors the more diversified, lower-cost, and more liquid U.S. large-cap exposure over the narrower, higher-cost single-country strategy.

Introduction

KORU and SPXL do not compete directly, but they frequently attract the same kind of investor: someone seeking amplified, short-term directional exposure through a leveraged exchange-traded fund (ETF). Both are daily-reset, 3x long products from the same issuer, Direxion, yet they target completely different markets. KORU concentrates leverage on a single country's equity index, while SPXL applies leverage to the broad U.S. S&P 500. Comparing them therefore illuminates a core investing question — whether to concentrate amplified risk in a narrow foreign market or to spread it across the world's largest and most liquid equities. Understanding their structural differences is essential before committing capital to either vehicle.

Direxion Daily MSCI South Korea Bull 3X ETF (KORU) Overview

KORU seeks daily investment results, before fees and expenses, of 300% of the performance of the MSCI Korea 25/50 Index. That benchmark is designed to measure the large- and mid-cap segments of the South Korean equity market, covering roughly 85% of the free float-adjusted market capitalization of South Korean issuers. The fund is non-diversified and achieves its leveraged exposure primarily through swap agreements and the iShares MSCI South Korea ETF (EWY), rather than by owning every underlying stock outright.

Concentration is a defining trait. Samsung Electronics and SK Hynix — two global memory-chip and semiconductor leaders — together represent a very large share of the underlying index. Sector-wise, information technology dominates at roughly 47% of the benchmark, followed by industrials (about 20%) and financials (about 11%). The net expense ratio is approximately 1.32%, and the fund resets its leverage daily, which can cause returns over periods longer than one day to diverge substantially from three times the index's cumulative return. This makes KORU a tactical, high-turnover trading tool rather than a long-term core holding.

Direxion Daily S&P 500 Bull 3X ETF (SPXL) Overview

SPXL seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P 500 Index. The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments such as swap agreements, index securities, and ETFs that, in combination, provide 3x daily leveraged exposure. Like KORU, it is non-diversified and relies heavily on swap contracts, holding cash and money-market instruments as collateral alongside a portion of direct index exposure.

SPXL tracks a market-cap-weighted index of roughly 500 leading U.S. large-cap companies, spanning all eleven major sectors. Information technology is the largest sector at roughly one-third of assets, followed by financials, communication services, and consumer discretionary. Its largest underlying positions include NVIDIA (NVDA), Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), and Alphabet (GOOGL). The net expense ratio is approximately 0.84% (gross expense ratio of about 0.95%). As with KORU, daily resetting means compounding and volatility drag can materially affect multi-day performance.

Industry and Thematic Backdrop

The two funds are shaped by very different macro and thematic forces. SPXL is anchored to the U.S. large-cap complex, where performance has been driven in recent market cycles by artificial-intelligence infrastructure spending, resilient corporate earnings, and Federal Reserve interest-rate policy. Its fortunes are closely tied to the earnings trajectory of mega-cap technology companies and to broad risk appetite across U.S. equities.

KORU, by contrast, is a concentrated bet on South Korea, a market heavily influenced by the global semiconductor cycle, memory-chip pricing, export demand, and the performance of its dominant technology exporters. Korean equities are also sensitive to corporate governance reform, currency movements, and regional geopolitical tensions. These dynamics can create sharp, sentiment-driven swings that are then amplified threefold by KORU's daily leverage, giving the fund a substantially higher volatility profile than SPXL.

Performance and Positioning Comparison

Over recent weeks and market cycles, both funds have delivered amplified gains during risk-on periods, but their relative positioning has diverged. SPXL has generally benefited from persistent U.S. large-cap leadership and broad-based sector participation, supported by steady index inflows and the earnings power of its top mega-cap holdings. Its diversification across eleven sectors has helped moderate idiosyncratic, single-stock shocks even as daily leverage amplifies market moves.

KORU has experienced more uneven performance, reflecting the cyclical nature of the memory-chip market and periodic rotation into and out of Korean exporters. Its heavy concentration in a handful of technology names means a rally or pullback in the semiconductor complex can disproportionately drive fund performance. Consequently, KORU has exhibited notably higher realized volatility than SPXL, with return dispersion driven less by broad market beta and more by single-country, single-sector momentum. For investors assessing relative positioning, SPXL offers a broader risk base, while KORU offers concentrated, higher-beta exposure to one of Asia's most cyclical equity markets.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market using technical patterns, fundamentals, trend strength, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters covering industry, market capitalization, technical indicators, price patterns, and performance metrics. By surfacing trade ideas, trending instruments, breakout candidates, and market opportunities far more efficiently than manual screening, the screener supports faster, more data-driven decisions. Explore the AI Screener to refine your own search.

Tickeron AI Verdict

Based on observable structural factors, Tickeron's AI currently favors SPXL. The fund offers broader diversification across roughly 500 U.S. large-cap names, a meaningfully lower expense ratio (about 0.84% versus 1.32%), deeper liquidity, and a more consistent trend profile tied to broad U.S. equity leadership. While KORU can deliver outsized returns during strong semiconductor upswings, its single-country concentration and higher volatility elevate the probability of sharp drawdowns when the memory-chip cycle turns. On a risk-adjusted, cost-adjusted basis, SPXL's combination of diversification, cost efficiency, and sector balance presents a more defensible core expression of leveraged equity exposure. This assessment reflects relative structural strength and is not intended as personalized investment advice.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations